About Us | FDA-Inspected Wholesale Peptide Supplier
Learn why pharmaceutical leaders choose CPC as their wholesale peptide supplier. FDA-inspected cGMP facility, Tirzepatide DMF filed, 25+ years experience.
Learn why pharmaceutical leaders choose CPC as their wholesale peptide supplier. FDA-inspected cGMP facility, Tirzepatide DMF filed, 25+ years experience.
When your procurement team evaluates a wholesale peptide supplier, regulatory credentials matter more than marketing claims. Chinese Peptide Company (CPC) is a wholly owned subsidiary of Medtide Inc. (HKEX: 03880), a publicly listed CRDMO with a cGMP manufacturing facility in Hangzhou, China, that has successfully completed a U.S. FDA Pre-License Inspection and filed a Drug Master File for Tirzepatide API . We supply bulk peptides to pharmaceutical, biotechnology, and diagnostic companies across the United States and more than 50 other countries.
This is not a story about a distributor who repackages vials in a warehouse. This is the story of a 25-year-old manufacturing organization that Gilead Sciences trusted to supply the commercial API for Hepcludex®, the first FDA-approved treatment for chronic hepatitis delta virus in the United States .
Chinese Peptide Company (CPC) is a peptide-focused business serving organizations seeking peptide synthesis services, technical manufacturing support, and wholesale project solutions. We aim to connect qualified research and industry customers with peptide-related services that match their technical specifications and project requirements.
Our website, Chinese Peptide Company, provides a central point for customers to learn about our business, explore our stated capabilities, and submit inquiries about peptide synthesis and manufacturing requirements.
We understand that choosing a peptide supplier involves more than comparing prices. Customers need clear product specifications, appropriate analytical documentation, responsive communication, and a reliable understanding of what a supplier can deliver. Our approach is built around these priorities.
Whether you are evaluating a custom peptide synthesis project, exploring manufacturing partnerships, or seeking information about peptide quality assessment, we encourage you to begin with a clear discussion of your requirements.
Contact Chinese Peptide Company today to discuss your project and request information about our available services.
Chinese Peptide Company is focused on peptide synthesis, manufacturing-related services, and business inquiries from qualified customers. We recognize the importance of technical accuracy, transparent communication, and clearly defined specifications throughout the supplier evaluation process.
Peptides are chains of amino acids that have important roles in biological research, biochemical analysis, and the development of scientific and diagnostic applications. Working with these materials can require careful attention to sequence design, synthesis feasibility, purification, analytical characterization, and appropriate documentation.
Our goal is to help prospective customers understand the requirements involved in a peptide project and determine whether our available capabilities are suitable for their needs.
We welcome relevant inquiries from research organizations, biotechnology companies, laboratories, and other qualified commercial or institutional customers, subject to the applicable legal and regulatory requirements.
Chinese Peptide Company maintains a website intended to serve relevant customers and organizations in the United States market.
Our business inquiries may involve custom peptide synthesis, manufacturing requirements, analytical specifications, and potential wholesale arrangements, subject to actual service availability and applicable laws.
Customers evaluating a peptide supplier should consider more than geographic location. They should also examine business identity, manufacturing arrangements, quality documentation, regulatory suitability, shipping requirements, and the intended use of the materials.
For US-related inquiries, customers should confirm the applicable federal and state requirements before placing an order or entering into a supply agreement.
Chinese Peptide Company was established in 2001 in Hangzhou, China . From the beginning, our mission was to solve the hardest problems in peptide synthesis—complex sequences, long chains, and modifications that other manufacturers declined to attempt.
CPC operates as a wholly owned subsidiary of Medtide Inc., which listed on the Main Board of The Stock Exchange of Hong Kong Limited in 2025 under stock code 03880 . This corporate structure provides the financial transparency, public accountability, and governance standards that pharmaceutical procurement teams require from a long-term supply partner.
The first half of 2026 marked two defining milestones. In February, we completed the FDA Pre-License Inspection for Hepcludex® API . In May, we filed our Tirzepatide API DMF . These achievements followed the May 22, 2026 FDA accelerated approval of Hepcludex®, for which CPC served as the commercial API supplier to Gilead Sciences .
We manufacture active pharmaceutical ingredients for clinical-stage and commercial products. Our portfolio includes complex long-chain peptides, GLP-1/GIP receptor agonists, and custom sequences. The Tirzepatide DMF represents our commitment to supporting regulatory pathways for our partners in the metabolic disease space .
For licensed laboratories and research institutions requiring larger quantities, we offer bulk research peptides with full analytical documentation. These products are sold strictly for in-vitro research use only.
Our custom synthesis team specializes in complex, long-chain, and modified peptides. From milligram feasibility studies to kilogram-scale commercial supply, we manage the entire lifecycle under one quality system. When you need a wholesale peptide supplier for a sequence that is not in our catalog, this is where we differentiate.
Our primary physical location is No. 69, 12 Street, Qiantang District, Hangzhou City, Zhejiang Province, China . This facility houses our peptide synthesis operations, quality control laboratories, and serves as our global headquarters. It is the site that underwent the FDA Pre-License Inspection in early 2026 .
Our international headquarters is located in California, USA, providing local support for North American clients navigating regulatory submissions, quality agreements, and supply chain logistics
Chinese Peptide Company focuses on peptide-related business inquiries, including peptide synthesis and manufacturing requirements. Customers should contact the company to confirm the services and capabilities available for their specific project.
Prepare the relevant sequence, modifications, target purity, quantity, intended use, and analytical requirements. Submit your inquiry through the company’s contact page so the request can be assessed.
CPC welcomes relevant business inquiries about potential wholesale and manufacturing arrangements. Availability, minimum quantities, specifications, and applicable compliance requirements should be confirmed directly.
Review the available analytical documentation, test methods, identity information, purity specifications, and relevant batch records. Confirm what each test demonstrates and whether the evidence meets your project’s requirements.
No. Purity is only one measure of a material’s characteristics. Identity, content, impurities, stability, and other considerations may also be relevant. Suitability depends on the intended application and its applicable requirements.
Materials intended for research are not automatically approved or suitable for human use. Pharmaceutical use requires the appropriate evidence, quality systems, and regulatory authorization applicable to the product and jurisdiction.
Visit https://chinesepeptidecompany.com and use the contact information provided on the website. Include your organization details and project requirements when making a business inquiry.
At Chinese Peptide Company, we recognize the importance of clear specifications, appropriate documentation, and informed supplier evaluation when planning a peptide-related project.
If you are researching custom peptide synthesis services, evaluating manufacturing options, or seeking information about potential wholesale arrangements, we invite you to contact our team.
Share your technical requirements and intended application so the relevant service options and project considerations can be reviewed.
Take the next step toward your peptide project. Contact Chinese Peptide Company today to discuss your requirements and request information about our available services.
CPC is led by Dr. Li Xiang, Chairman of Chinese Peptide Company . Our parent company, Medtide Inc., is publicly listed on the Hong Kong Stock Exchange (HKEX: 03880), providing the governance and financial transparency that pharmaceutical procurement teams expect from a critical supply partner .
Get in touch